optimal levels are 40-60 ng/mL
I feel energized, lighter, and completely in control
NextMed Founded: 2020 Total raised: Undisclosed What NextMed does: NextMed began as a COVID-19 testing startup but moved into prescribing GLP-1s for weight loss in July 2022
The Bottom Line BPC-157 dosage depends on your weight, delivery route, and treatment goal
The full article is available in Alcoholism & Drug Abuse Weekly's January 19, 2026 edition and online To view or add a comment, sign in New Medicaid spending data just released shows a clear strategic signal: behavioral health and home-based services are where the dollars flow not procedures
By Drug Type, Liraglutide Segment Accounts for 35.5% Market Share The liraglutide segment is projected to account for 35.5% of the GLP-1 diabetes treatment drugs market in 2025, reaffirming its position as the leading drug type category